Christine C Hughes is a pharmacist who is specialized in Oncology in Tulsa, Oklahoma. Patients can reach her at 1245 S Utica Ave Ste 100, Tulsa or contact her on 918-579-3850. Active license number of Christine C Hughes is 17037 for Oncology in Oklahoma. Christine C Hughes is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Christine C Hughes speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Christine C Hughes
Specialization:
Oncology
Credentials:
PHARMD
Gender:
Female
Location:
1245 S Utica Ave Ste 100, Tulsa, Oklahoma, 74104-4214
Phone:
918-579-3850
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Christine C Hughes are as mentioned below.
NPI Number:
1568287639
NPI Enumeration Date:
22 Nov, 2024
NPI Last Update On:
22 Nov, 2024
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Christine C Hughes are as mentioned below.
Specialization
License Number
State
Status
Oncology
17037
Oklahoma
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1207 S Evanston Ave, Tulsa, Oklahoma
Zip:
74104-4133
Phone Number:
510-205-2787
Fax Number:
--
Patients can reach Christine C Hughes at 1245 S Utica Ave Ste 100, Tulsa, Oklahoma or can call on phone at 918-579-3850.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.